AU2002339697A1 - Gmg-5 polynucleotides and polypeptides and uses thereof - Google Patents

Gmg-5 polynucleotides and polypeptides and uses thereof

Info

Publication number
AU2002339697A1
AU2002339697A1 AU2002339697A AU2002339697A AU2002339697A1 AU 2002339697 A1 AU2002339697 A1 AU 2002339697A1 AU 2002339697 A AU2002339697 A AU 2002339697A AU 2002339697 A AU2002339697 A AU 2002339697A AU 2002339697 A1 AU2002339697 A1 AU 2002339697A1
Authority
AU
Australia
Prior art keywords
gmg
polynucleotides
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002339697A
Other versions
AU2002339697A8 (en
Inventor
Deno Dialynas
Aaron Scalia
Hiroaki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Publication of AU2002339697A8 publication Critical patent/AU2002339697A8/en
Publication of AU2002339697A1 publication Critical patent/AU2002339697A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002339697A 2001-12-19 2002-10-29 Gmg-5 polynucleotides and polypeptides and uses thereof Abandoned AU2002339697A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34344001P 2001-12-19 2001-12-19
US60/343,440 2001-12-19
PCT/IB2002/004806 WO2003051911A2 (en) 2001-12-19 2002-10-29 Gmg-5 polynucleotides and polypeptides and uses thereof

Publications (2)

Publication Number Publication Date
AU2002339697A8 AU2002339697A8 (en) 2003-06-30
AU2002339697A1 true AU2002339697A1 (en) 2003-06-30

Family

ID=23346124

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002339697A Abandoned AU2002339697A1 (en) 2001-12-19 2002-10-29 Gmg-5 polynucleotides and polypeptides and uses thereof

Country Status (2)

Country Link
AU (1) AU2002339697A1 (en)
WO (1) WO2003051911A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001055310A2 (en) * 2000-01-31 2001-08-02 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
AU4726901A (en) * 2000-03-02 2001-09-12 Lexicon Genetics Inc Novel human proteins and polynucleotides encoding the same
WO2002055694A2 (en) * 2001-01-16 2002-07-18 Genset Sa Discriminative nucleic acid analysis using clone sequence signatures

Also Published As

Publication number Publication date
AU2002339697A8 (en) 2003-06-30
WO2003051911A2 (en) 2003-06-26
WO2003051911A3 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
AU2002341541A1 (en) Abiotic stress responsive polynucleotides and polypeptides
HUP0500989A2 (en) Animicrobial polypeptides and their uses
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
AU2002252705A1 (en) Polynucleotides and polypeptides associated with the nf-kb pathway
IL153568A (en) Novel polypeptides and polynucleotides
EP1409661A4 (en) Hdac9 polypeptides and polynucleotides and uses thereof
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
AU2002241899A1 (en) Tip39 polypeptides
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
AU2002256276A1 (en) Novel expansin polynucleotides, related polypeptides and methods of use
AU2002319176A1 (en) Polynucleotides and polypeptides of the ifnalpha-5 gene
AU2002327676A1 (en) Novel polynucleotides and proteins encoded thereby
AU2002317867A1 (en) New polynucleotides and polypeptides of the ifnalpha-7 gene
AU2002351469A1 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
AU2002303284A1 (en) Protection-of-telomere-1 (pot-1) protein and encoding polynucleotides
AUPR974101A0 (en) Novel polynucleotides and uses therefor
AU2002316891A1 (en) Polynucleotides and polypeptides of the ifnalpha-6 gene
AU2002251433A1 (en) Gssp3 polynucleotides and polypeptides and uses thereof
AU2002318186A1 (en) Novel human kielin-like proteins and polynucleotides encoding the same
AU2001255832A1 (en) Orfx polynucleotides and polypeptides
AU2002360460A1 (en) Methods and materials relating to novel polypeptides and polynucleotides
AU2002310002A1 (en) Ccl1 polynucleotides and polypeptides and uses thereof
AU2003240755A1 (en) Xcrf polynucleotides and polypeptides and uses thereof
AU2002227496A1 (en) Polynucleotides and polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase